Tag: Agreement
US: Arrowhead, Janssen sign US$3.7b license and collaboration deal
Arrowhead Pharmaceuticals has signed a license and collaboration agreement with Janssen Pharmaceuticals for the development and commercialization of hepatitis B virus (HBV) treatment, ARO-HBV.
ARO-HBV...